Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pliant Therapeutics Inc (NQ: PLRX )

35.70 -0.56 (-1.54%)
Streaming Delayed Price Updated: 12:42 PM EST, Jan 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 438,546
Open 36.17
Bid (Size) 35.66 (3)
Ask (Size) 35.73 (2)
Prev. Close 36.26
Today's Range 35.50 - 36.64
52wk Range 3.965 - 36.50
Shares Outstanding 35,937,937
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Why Pliant Therapeutics Stock Is Skyrocketing This Week
The company's experimental idiopathic pulmonary fibrosis drug is showing a lot of promise. 
Via The Motley Fool
Pliant Therapeutics Announces Appointment of Lily Cheung as Chief Human Resources Officer
From Pliant Therapeutics, Inc.
Via Globe NewsWire

Performance

YTD
+87.89%
+87.89%
1 Month
+92.45%
+92.45%
3 Month
+47.76%
+47.76%
6 Month
+103.19%
+103.19%
1 Year
+201.01%
+201.01%

More News

Read More
Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
Via MarketBeat
Pliant Therapeutics Announces Pricing of Upsized $250.0 Million Public Offering
From Pliant Therapeutics, Inc.
Via Globe NewsWire
Expert Ratings for Pliant Therapeutics
Via Benzinga
An Unexpected Feat Just Sent Pliant Therapeutics Soaring More Than 50%
Via Investor's Business Daily
Pliant Therapeutics Announces Proposed Public Offering of Common Stock
From Pliant Therapeutics, Inc.
Via Globe NewsWire
Nasdaq Rises 1.5%; Pliant Therapeutics Shares Spike Higher
Via Benzinga
Dow, Nasdaq Boasting Triple-Digit Midday Lead
Via Talk Markets
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Evoqua Water Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Dow Jumps Over 300 Points; Crude Oil Up 1%
Via Benzinga
Pliant Therapeutics (NASDAQ: PLRX) Reports Positive Phase 2 Clinical Trial Data of Bexotegrast in Treatment of Idiopathic Pulmonary Fibrosis
Via Spotlight Growth
US Stocks Mostly Higher; Synchrony Financial Earnings Top Views
Via Benzinga
Why Is Xylem (XYL) Stock Down 9% Today
Via InvestorPlace
Why Is Ryvyl (RVYL) Stock Is On the Move Today?
Via InvestorPlace
Benzinga's Talk of the Town: Top Social Trending Stories You Need To Know
Via Benzinga
Why Is Pliant Therapeutics (PLRX) Stock Up 62% Today?
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Pliant Therapeutics Shares Are Trading Higher By Around 49%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Pliant Therapeutics Stock Surges After Positive Data From Lead Program In Scarred Lung Disorder
Via Benzinga
Salesforce, Tesla And Other Big Stocks Moving Higher In Monday's Pre-Market Session
Via Benzinga
Pliant Therapeutics Announces Positive Data from the INTEGRIS-IPF Phase 2a Trial Demonstrating Bexotegrast 320 mg was Well Tolerated and Achieved Statistically Significant FVC Increase in Patients with Idiopathic Pulmonary Fibrosis
From Pliant Therapeutics, Inc.
Via Globe NewsWire
Pliant Therapeutics to Participate in the 41st Annual J.P. Morgan Healthcare Conference
From Pliant Therapeutics, Inc.
Via Globe NewsWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.